Related Experiment Video
Updated: Sep 18, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Reducing EHR navigation time with an advanced hyperlipidemia management Tool: An evaluation of efficiency
Chin-Chen Chen1, Yu-Chen Liu2, Guan-Ling Lin3
1Information Technology Department, Cardinal Tien Hospital, New Taipei City, Taiwan; Information Technology Department, Yonghe Cardinal Tien Hospital, New Taipei City, Taiwan; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
A new Hyperlipidemia Medication Reminder System (HLD-MRS) significantly reduced electronic health record navigation time and improved patient monitoring for hyperlipidemia care. This system enhances efficiency in busy outpatient settings.
Area of Science:
- Cardiovascular Medicine
- Health Informatics
- Clinical Decision Support Systems
Background:
- Effective hyperlipidemia management is vital for cardiovascular disease prevention.
- Traditional electronic health record (EHR) systems present challenges in efficiently identifying and tracking patients at risk for hyperlipidemia.
- Streamlining EHR navigation is essential for improving patient care workflows.
Purpose of the Study:
- To evaluate the impact of a Hyperlipidemia Medication Reminder System (HLD-MRS) on EHR navigation efficiency.
- To assess the system's effectiveness in enhancing patient tracking and management for hyperlipidemia.
- To determine the system's utility in a district hospital setting.
Main Methods:
- A pre-post prospective study design was employed.
- The HLD-MRS was developed to integrate patient data, clinical guidelines, and risk assessments into a unified interface.
- EHR navigation times and patient monitoring rates were compared before and after HLD-MRS implementation across multiple departments.
Main Results:
- The HLD-MRS implementation led to a significant reduction in mean EHR navigation time from 83.9s to 53.8s (p < 0.001).
- The proportion of actively monitored hyperlipidemia patients increased from 42.5% to 56.6%.
- The rate of unknown or withheld assessment status decreased substantially from 57.5% to 28.4%.
Conclusions:
- The HLD-MRS demonstrably improved EHR navigation efficiency and increased active patient monitoring for hyperlipidemia.
- This guideline-driven decision support tool shows considerable potential for optimizing hyperlipidemia care in high-volume outpatient environments.
- The system offers a promising solution for enhancing clinical workflows and patient outcomes in managing hyperlipidemia.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Angina V: Nursing Management
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care
Heart Failure V: Medical Management

